Scientists may have achieved a breakthrough in the treatment of age-related diseases: by rejuvenating cells, they have been able to restore vision in mice – a therapy that could be used in humans to treat glaucoma and other age-related conditions, and possibly even dementia.
The procedure offers the possibility of effectively turning back the clock at a cellular level, helping cells to regain their ability to repair damage after this capacity has rapidly declined due to ageing.
The researchers therefore modified a process that produces a specific type of stem cell. These cells are generated by a cocktail of four proteins that help to reprogramme a cell. To restore the cells to a youthful state, they injected mice with optic nerve damage with three of the four proteins in the cocktail.
Tests showed that half of the visual acuity lost due to increased intraocular pressure was restored. The treatment yielded similarly promising results in older mice with age-related visual impairment. After the cocktail had been injected, the mice’s vision improved. No side effects occurred during the course of the study. The researchers anticipate that the treatment of glaucoma in humans could be available within two years.
Reference:
Harvard Medical School; Massachusetts General Hospital; University of California; Yale School of Medicine
Original publication: Reprogramming to recover youthful epigenetic information and restore vision. *Nature* 588:124–129 (2020); https://doi.org/10.1038/s41586-020-2975-4